|1.||Soga, Tomoyoshi: 2 articles (01/2014 - 03/2010)|
|2.||Jenkinson, Helen: 1 article (10/2015)|
|3.||Peet, Andrew C: 1 article (10/2015)|
|4.||Brundler, Marie-Anne: 1 article (10/2015)|
|5.||Kohe, Sarah: 1 article (10/2015)|
|6.||McConville, Carmel M: 1 article (10/2015)|
|7.||Parulekar, Manoj: 1 article (10/2015)|
|8.||Wilson, Martin: 1 article (10/2015)|
|9.||Tomi, M: 1 article (06/2015)|
|10.||Duereh, M: 1 article (06/2015)|
07/01/2012 - "Hypotaurine may regulate nociceptive transmission physiologically by activating glycinergic neurons in the spinal cord, and it is a promising candidate for treating various pain states."
07/01/2012 - "To determine which neurotransmitter pathway(s) was involved in the action of hypotaurine, in this study, we examined how the antagonists of spinal pain processing receptors altered the effect of 600 μg hypotaurine. "
|2.||Neuralgia (Stump Neuralgia)
07/01/2012 - "This study demonstrated that intrathecal hypotaurine suppressed acute, inflammatory, and neuropathic pain. "
07/01/2012 - "This study used behavioral assessments to determine whether hypotaurine influenced nociceptive transmission in acute, inflammatory, and neuropathic pain. "
07/01/2012 - "Antinociceptive effect of intrathecal administration of hypotaurine in rat models of inflammatory and neuropathic pain."
|3.||Glioblastoma (Glioblastoma Multiforme)
|4.||Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/01/2015 - "Here, we study Type 1 Diabetes Mellitus (T1D), focusing on growth of glutamate, β-alanine, taurine and hypotaurine, and butanoate metabolisms involved in onset of GAD and INS genes in Homo sapiens with comparative analysis in non-obese diabetic Mus musculus, biobreeding Diabetes-prone Rattus norvegicus, Pan troglodytes, Oryctolagus cuniculus, Danio rerio and Drosophila melanogaster respectively. "
|5.||Body Weight (Weight, Body)
01/01/1995 - "Sulfate excretion increased significantly when more than 3 mmol of hypotaurine per kg of body weight was injected. "
01/01/1995 - "The total excretion and the increased excretion (difference of those before and after the loading) were 2328 +/- 219 and 1948 +/- 153 mumol per kg of body weight per day, respectively, at 7 mmol of hypotaurine loading. "
07/01/2006 - "Increased contents (micromol/g of wet tissue) over the control of taurine and hypotaurine in mouse tissues at 60 min after the injection of 5.0 mmol/kg body weight of CSA were: liver, 3.5 and 9.9; kidney, 0.3 and 5.2; heart, 3.7 and 0.2; blood plasma, 0.4 and 0.2, respectively. "
07/01/2006 - "When 5.0 mmol/kg of body weight of CSA was injected to rats, increased urinary excretions of taurine, hypotaurine and sulfate in 24 h urine were 617, 52 and 1,767 micromol/kg, respectively. "
04/01/1998 - "The average excretions of total taurine (taurine plus hypotaurine) and total sulfate (free plus ester sulfate) (mumol/kg of body weight per day after the adaptation to the synthetic diet) in group A were 14.2 +/- 13.4 and 122.3 +/- 39.6, respectively, which were very low compared with 280.4 +/- 93.8 and 943.2 +/- 144.8, respectively, in group B. "
|2.||Glutamic Acid (Glutamate)
|4.||Neurotransmitter Agents (Neurotransmitter)
|5.||Uridine Diphosphate (UDP)
|6.||Glycine (Aminoacetic Acid)
|7.||Biological Markers (Surrogate Marker)